Sanofi is committed to discovering, developing, and delivering medicines and vaccines for patients in need. Unfortunately, thousands of patients around the world can’t access these life-saving treatments through commercial channels due to geographic location or financial circumstances. To help dismantle these barriers, Sanofi has implemented a series of humanitarian aid programs that work to deliver treatments to those who wouldn’t otherwise have access. The Rare Humanitarian Program is the first, the largest, and the longest running program of its kind to treat patients with lysosomal storage disorders — a group of rare genetic conditions caused by enzyme deficiencies.
Although the Rare Humanitarian Program has been running for over 30 years, Sanofi unlocked a new way to expedite applications and accelerate approvals in early 2023 when they moved the program onto Bonterra’s Grants Management solution.
